| Literature DB >> 35978748 |
Georgios Tsalimas1, Dimitrios Stergios Evangelopoulos2, Ioannis S Benetos3, Spiros Pneumaticos4.
Abstract
Anterior cervical discectomy and fusion (ACDF), despite its possible complications, remains the gold standard for the surgical treatment of patients with radiculopathy and/or myelopathy caused by cervical intervertebral disc herniation or spondylosis. Despite its high rate of incidence, postoperative dysphagia following ACDF is still poorly understood; its pathogenesis remains relatively unknown, and its risk factors are still a subject of debate. The aim of this study is to review the incidence, pathogenesis, diagnosis, and methods of prevention of dysphagia in ACDF patients. To this end, a literature review was conducted based on the PubMed internet database. Article titles were searched by using the following keywords: "dysphagia" and "anterior cervical discectomy and fusion" or "ACDF". The search was limited to prospective clinical studies evaluating dysphagia after ACDF surgery. Studies published in non-English languages, retrospective studies, cadaveric studies, reviews, case reports, study protocols, and commentary studies were excluded. Initially, 335 studies were identified after a primary search. After the application of the exclusion criteria, 73 studies remained for the final analysis. This literature review focused on identifying the rate of dysphagia and the various risk factors leading to this complication by comparing and evaluating the current literature with a wide spectrum of heterogeneity concerning patients, surgeons, and surgical techniques. A mean dysphagia rate of 19.4% (95% CI: 9.6%-29.1%) based on the findings of the included studies correlating dysphagia directly with ACDF procedures was calculated. Various established risk factors leading to dysphagia include the female sex, smoking, the surgical approach, rhBMP-2 use, and multilevel surgery, while zero-profile devices seem to reduce dysphagia risk. The diagnosis is based on clinical and radiological findings, especially prevertebral soft-tissue swelling. However, videofluoroscopic and endoscopic studies have been recently used for the evaluation of dysphagia. The role of local administration of steroids in the prevention of dysphagia has not yet been clarified. This review underscores the prevailing rudimentary understanding of the problem of dysphagia after ACDF procedures and highlights the need for more sensitive, factor-specific studies for understanding the impact of various risk factors on the incidence rate of dysphagia.Entities:
Keywords: acdf; acdf complications; anterior cervical discectomy and fusion; dysphagia; postoperative dysphagia
Year: 2022 PMID: 35978748 PMCID: PMC9375980 DOI: 10.7759/cureus.26888
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Study selection flowchart
Dysphagia incidence and ACDF: study characteristics
ACDF: anterior cervical discectomy and fusion; ACCF: anterior cervical corpectomy and fusion
| Authors, year | Study design | Patient details | Interventions (operated levels) | Follow-up time intervals | Graft type |
| Riley et al., 2005 [ | Registry cohort study | N=454, mean age: 48.2 years, % male: 52.2 | ACDF | 3, 6, and 24 months | N/A |
| Bazaz et al., 2002 [ | Prospective cohort | N=249, mean age: 52 years, no. of males: 52 | ACDF or ACCF with or without plate or graft revision | 6 months | Autograft |
| Haller et al., 2022 [ | Prospective study | N=56, mean age: 60 years, no. of females: 33 | ACDF | 2, 12, and 24 months | N/A |
| Kepler et al., 2012 [ | Prospective cohort | N=43 | ACDF one level: n=15, two levels: n=28 | 1.5 months | Autograft or allograft |
| Bruneau et al., 2001 [ | Prospective cohort | N=54 | ACDF one level: n=40, two levels: n=14 | 24.6 months | Hydroxyapatite |
| Lied et al., 2013 [ | Prospective single-center | N=96, mean age: 49 years, no. of females: 33 | ACDF one level: n=60, two levels: n=36 | 6 months | N/A |
| Opsenak et al., 2019 [ | Prospective single-center study | N=73 | ACDF (zero-profile) | 6 weeks; 3, 6, and 12 months | Allograft |
| Srikhande et al., 2019 [ | Prospective study | N=100, mean age: 47.2 years, no. of females: 14 | ACDF one level: n ¼ 95, two levels: n ¼ 5 | 24 months | Autograft |
| Frempong-Boadu et al., 2002 [ | Prospective cohort | N=23, mean age: 59 years, % male: 95.6 | ACDF (up to three levels) | 1 week post-op, 12 months | Allograft |
| Mendoza-Lattes et al., 2008 [ | Prospective cohort | N=17, mean age: 47.8 years, % male: 35.3 | ACDF with either dynamic retraction or static retraction one level: n=7, two levels: n=10 | 1st day post-op, 6 weeks, 3 and 6 months | Allograft |
| Papavero et al., 2007 [ | Prospective cohort | N=92, mean age: NR, % male: 57.6 | ACDF using predominantly a left-sided Smith-Robinson approach | 1st, 3rd, and 5th post-op day | N/A |
| Hou et al., 2014 [ | Prospective cohort | N=196 | ACDF one level: n=108, two levels: n=88 | 22.5 months | Autograft |
| Song and Lee, 2006 [ | Prospective cohort | N=39, mean age: 46.3 years | ACDF one level | 24 months | Autograft |
| Bolesta et al., 2000 [ | Prospective cohort | N=15, mean age: 51 years, no. of males: 5, no. of females: 10 | ACDF three levels: n=12, four levels: n=3 | 42 months | Autograft |
| O'Donohoe et al., 2020 [ | Prospective cohort | N=25, mean age: 55.79 years, no. of females: 17 | ACDF one level | 2 years | Allograft |
| Lee et al., 2005 [ | Prospective cohort | N=156 | ACDF with 2 different plates: Atlantis and Zephir | 1, 2, 6, 12, and 24 months | Allograft |
| Grasso et al., 2018 [ | Prospective study | N=100 | ACDF (zero-profile implants) | 4 years | N/A |
| Zhang et al., 2016 [ | Prospective cohort | N=50, mean age: 50.65 years, no. of males: 24, no. of females: 26 | ACDF (zero-profile implants and anterior plate and cage) | 2 years | N/A |
| De Leo-Vargas et al., 2019 [ | Prospective study | N=53, mean age: 58.8 years | ACDF | 6.7 months | N/A |
| Scholz et al., 2011 [ | Prospective study | N=38, mean age: 53.7 years, no. of males: 24, no. of females: 14 | ACDF (zero-profile implants) | 6 months | N/A |
| El Baz et al., 2019 [ | Prospective study | N=25, no. of males: 21, no. of females: 4 | ACDF (zero-profile cage) | 6 months (average follow-up time) | N/A |
| Gerszten et al., 2016 [ | Prospective study | N=68, mean age: 56 years, no. of males: 51, no of females: 17 | ACDF (zero-profile fixation and stand-alone PEEK cages) | 6 months | Allograft |
| Grasso et al., 2014 [ | Prospective study | N=32, mean age: 59.8 years, no. of males: 18, no of females: 14 | ACDF (ROI-C cages) | 6 weeks; 3, 6, 12, and 24 months | Allograft (cadaveric bony tissue) |
| Chen et al., 2015 [ | Prospective study | N=69, mean age: 49.2 years, no. of males: 41, no of females: 28 | ACDF (Zero-P spacer, two-level fusion) | 2-6 months | N/A |
| He et al., 2018 [ | Prospective randomized trial | N=104, mean age: 57.4 years, no. of males: 55, no of females: 49 | ACDF (zero-profile implants and traditional anterior cervical plate) | 24 months | Autograft and allograft |
| Qizhi et al., 2016 [ | Prospective cohort | N=17, mean age: 60.7 years, no. of males: 12, no. of females: 5 | ACDF (zero-profile implants) | 48, 59 months | N/A |
Dysphagia rates and 95% confidence intervals (CIs) as per the studies
| Study | Dysphagia rate (95% CI) |
| Bazaz et al., 2002 [ | 12.5% (2.8%-22.2%) |
| Bolesta et al., 2000 [ | 6.7% (-3.0%-16.4%) |
| Bruneau et al., 2001 [ | 1.9% (-7.8%-11.6%) |
| Chen et al., 2015 [ | 15.6% (5.9%-25.3%) |
| De Leo-Vargas et al., 2019 [ | 3.7% (-6.0%-13.4%) |
| El Baz et al., 2019 [ | 8.0% (-1.7%-17.7%) |
| Frempong-Boadu et al., 2002 [ | 63.6% (53.9%-73.3%) |
| Grasso et al., 2014 [ | 6.25% (-3.5%-15.9%) |
| Grasso et al., 2018 [ | 2.0% (-7.7%-11.7%) |
| Haller et al., 2022 [ | 3.8% (-5.9%-13.5%) |
| He et al., 2018 [ | 8.0% (-1.7%-17.7%) |
| Hou et al., 2014 [ | 9.7% (-0.02%-19.4%) |
| Kepler et al., 2012 [ | 39.0% (29.3%-48.7%) |
| Lee et al., 2005 [ | 11.0% (1.3%-20.7%) |
| Lied et al., 2013 [ | 2.1% (-7.6%-11.8%) |
| Mendoza-Lattes et al., 2008 [ | 52.9% (43.2%-62.6%) |
| O'Donohoe et al., 2020 [ | 16.0% (6.3%-25.7%) |
| Opsenak et al., 2019 [ | 22.0% (12.3%-31.7%) |
| Papavero et al., 2007 [ | 49.3% (39.6%-59.0%) |
| Qizhi et al., 2016 [ | 5.9% (-3.8%-15.6%) |
| Riley et al., 2005 [ | 21.3% (11.6%-31.0%) |
| Scholz et al., 2011 [ | 2.6% (-7.1%-12.3%) |
| Song and Lee, 2006 [ | 2.6% (-7.1%-12.3%) |
| Srikhande et al., 2019 [ | 16.0% (6.3%-25.7%) |
| Zhang et al., 2016 [ | 14.3% (4.6%-24.0%) |
| Mean dysphagia rate | 19.4% (9.6%-29.1%) |
Figure 2Dysphagia rates and 95% confidence intervals (CIs) as per studies correlating dysphagia with ACDF, expressed in a forest plot for meta-analysis
ACDF: anterior cervical discectomy and fusion